Townsquare Capital LLC Genmab A/S Transaction History

Townsquare Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $409,182 - $569,708	12,106 New	12,106 $513,000
Q1 2022 Apr 28, 2022	SELL	$30.95 - $39.68 $168,801 - $216,414	-5,454 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$35.87 - $47.12 $39,134 - $51,407	-1,091 Reduced 16.67%	5,454 $216,000
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $271,944 - $318,872	6,545 New	6,545 $286,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.